These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29667415)

  • 21. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    Mohammad Alizadeh AH; Abbasinazari M; Hatami B; Abdi S; Ahmadpour F; Dabir S; Nematollahi A; Fatehi S; Pourhoseingholi MA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):349-354. PubMed ID: 27849643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitroglycerin as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis.
    Tomoda T; Kato H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Matsumoto K; Yamamoto N; Horiguchi S; Tsutsumi K; Okada H
    Acta Med Okayama; 2016 Octoaber; 70(5):405-408. PubMed ID: 27777436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rectal administration of low-dose diclofenac does not reduce post-endoscopic retrograde cholangiopancreatography pancreatitis: a propensity score matching analysis.
    Sakai H; Iwai N; Sakagami J; Okuda T; Ohara T; Hattori C; Taniguchi M; Oka K; Hara T; Tsuji T; Komaki T; Kagawa K; Dohi O; Yasuda H; Konishi H; Itoh Y
    Surg Endosc; 2023 Apr; 37(4):2698-2705. PubMed ID: 36443561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
    Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
    Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J
    Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
    Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
    Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Khoshbaten M; Khorram H; Madad L; Ehsani Ardakani MJ; Farzin H; Zali MR
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e11-6. PubMed ID: 17683501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
    Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
    Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
    Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramuscular diclofenac for the prevention of post-ERCP pancreatitis: a randomized trial.
    Park SW; Chung MJ; Oh TG; Park JY; Bang S; Park SW; Song SY
    Endoscopy; 2015 Jan; 47(1):33-9. PubMed ID: 25409167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials.
    Patai Á; Solymosi N; Mohácsi L; Patai ÁV
    Gastrointest Endosc; 2017 Jun; 85(6):1144-1156.e1. PubMed ID: 28167118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial.
    Otsuka T; Kawazoe S; Nakashita S; Kamachi S; Oeda S; Sumida C; Akiyama T; Ario K; Fujimoto M; Tabuchi M; Noda T
    J Gastroenterol; 2012 Aug; 47(8):912-7. PubMed ID: 22350703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy: can rectal NSAIDs prevent post-ERCP pancreatitis?
    Testoni PA
    Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):429-30. PubMed ID: 22710572
    [No Abstract]   [Full Text] [Related]  

  • 35. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial.
    Luo H; Zhao L; Leung J; Zhang R; Liu Z; Wang X; Wang B; Nie Z; Lei T; Li X; Zhou W; Zhang L; Wang Q; Li M; Zhou Y; Liu Q; Sun H; Wang Z; Liang S; Guo X; Tao Q; Wu K; Pan Y; Guo X; Fan D
    Lancet; 2016 Jun; 387(10035):2293-2301. PubMed ID: 27133971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rectal indomethacin or intravenous gabexate mesylate as prophylaxis for acute pancreatitis post-endoscopic retrograde cholangiopancreatography.
    Guglielmi V; Tutino M; Guerra V; Giorgio P
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5268-5274. PubMed ID: 29228444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
    Wan J; Ren Y; Zhu Z; Xia L; Lu N
    BMC Gastroenterol; 2017 Mar; 17(1):43. PubMed ID: 28298192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis of pancreatitis with intravenous ketoprofen in a consecutive population of ERCP patients: a randomized double-blind placebo-controlled trial.
    de Quadros Onófrio F; Lima JCP; Watte G; Lehmen RL; Oba D; Camargo G; Dos Santos CEO
    Surg Endosc; 2017 May; 31(5):2317-2324. PubMed ID: 27651353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic Effect of Rectal Indomethacin Administration, with and without Intravenous Hydration, on Development of Endoscopic Retrograde Cholangiopancreatography Pancreatitis Episodes: A Randomized Clinical Trial.
    Hosseini M; Shalchiantabrizi P; Yektaroudy K; Dadgarmoghaddam M; Salari M
    Arch Iran Med; 2016 Aug; 19(8):538-43. PubMed ID: 27544361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of high-dose rectal diclofenac suppository and epinephrine spray on duodenal papilla for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Dar HA; Shah A; Javid G; Khan MA; Singh B; Sheikh NA; Ashraf A; Mohammad S
    Indian J Gastroenterol; 2021 Oct; 40(5):483-491. PubMed ID: 34767149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.